Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huanghou Zhixie dripping pills is a traditional Chinese medicine (TCM) formulation developed by Anhui Lei Yun Shang Pharmaceutical for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). It is specifically indicated for patients presenting with the TCM pattern of damp-heat in the large intestine. The drug is currently being evaluated in Phase II clinical trials in China to assess its efficacy and safety in adults meeting Rome IV criteria for IBS-D. As a TCM dripping pill formulation, it likely contains botanical extracts aimed at clearing heat, resolving dampness, and regulating gastrointestinal motility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huanghou Zhixie dripping pills.